Home
>
National Drug Code (NDC)
>
Cyclobenzaprine Hydrochloride
Cyclobenzaprine Hydrochloride - 0615-3520-05 - (cyclobenzaprine hydrochloride)
Drug Information of Cyclobenzaprine Hydrochloride
| Product NDC: | 0615-3520 |
| Proprietary Name: | Cyclobenzaprine Hydrochloride |
| Non Proprietary Name: | cyclobenzaprine hydrochloride |
| Active Ingredient(s): | 10 mg/1 & nbsp; cyclobenzaprine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cyclobenzaprine Hydrochloride
| Product NDC: | 0615-3520 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077797 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070228 |
Package Information of Cyclobenzaprine Hydrochloride
| Package NDC: | 0615-3520-05 |
| Package Description: | 15 TABLET, FILM COATED in 1 BLISTER PACK (0615-3520-05) |
NDC Information of Cyclobenzaprine Hydrochloride
| NDC Code | 0615-3520-05 |
| Proprietary Name | Cyclobenzaprine Hydrochloride |
| Package Description | 15 TABLET, FILM COATED in 1 BLISTER PACK (0615-3520-05) |
| Product NDC | 0615-3520 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cyclobenzaprine hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20070228 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
